NVTA 0.00 Stock Price Invitae Corporation
Range: | 0.015-2.34 | Vol Avg: | 12701614 | Last Div: | 0 | Changes: | -0.01 |
Beta: | 1.59 | Cap: | 0.01B | Currency: | USD | Exchange: | NYSE |
Sector: | Healthcare | IPO: | Thu Feb 12 2015 | Empoloyees: | 1700 |
CUSIP: | 46185L103 | CIK: | 0001501134 | ISIN: | US46185L1035 | Country: | US |
CEO: | Mr. Kenneth D. Knight | Website: | https://www.invitae.com |
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.